2022-12-11
2022-11-15
2022-11-25
2022-11-17
2022-11-22
2022-11-21
2022-11-15
2022-11-21
2022-11-16
2022-11-24
2022-12-06
2023-03-16
2023-08-21
里程碑!两款基因编辑疗法在美获批,标价百万美元,国内公司有哪些布局?
2023-12-13
2023-04-14
“基因编辑第一股”百奥赛图启动科创板IPO辅导,布局抗体药物开发全产业链
2023-01-03